Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for HER-2 status in breast cancer and its relationship to clinicopathological characteristics

LIN Hui-yun; XU Chun-wei; LI Hong-xia; ZHANG Li-ying; GAO Lan-xiang

doi:10.3969/j.issn.1007-8096.2013.08.011

Home>Articles>Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for HER-2 status in breast cancer and its relationship to clinicopathological characteristics

DOI: 10.3969/j.issn.1007-8096.2013.08.011

Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for HER-2 status in breast cancer and its relationship to clinicopathological characteristics

LIN Hui-yun

XU Chun-wei

LI Hong-xia

ZHANG Li-ying

GAO Lan-xiang

Keywords：Breast neoplasmHuman epidermal growth factor receptor 2Fluorescence in situ hybridizationImmunohistochemistry

Publication Date：2013-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 491-494 )

Chinese Journal of Diagnostic Pathology

PKUISTIC

ISSN：1007-8096

Year, Vol.(Issue)：2013,20(8)